Goodwill and Intangible Assets (Tables)
|
9 Months Ended |
Jun. 29, 2013
|
Goodwill And Intangible Assets Disclosure [Abstract] |
|
Rollforward of Goodwill Activity by Reportable Segment |
A rollforward
of goodwill activity by reportable segment from September 29,
2012 to June 29, 2013 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Breast Health |
|
|
Diagnostics |
|
|
GYN Surgical |
|
|
Skeletal Health |
|
|
Total |
|
Balance at
September 29, 2012
|
|
$ |
635,741 |
|
|
$ |
2,283,447 |
|
|
$ |
1,015,466 |
|
|
$ |
8,125 |
|
|
$ |
3,942,779 |
|
Gen-Probe acquisition
adjustments
|
|
|
— |
|
|
|
(3,526 |
) |
|
|
— |
|
|
|
— |
|
|
|
(3,526 |
) |
Chindex
acquisition
|
|
|
1,798 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,798 |
|
SenoRx
acquisition
|
|
|
692 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
692 |
|
Tax adjustments
|
|
|
— |
|
|
|
(674 |
) |
|
|
12 |
|
|
|
— |
|
|
|
(662 |
) |
Foreign currency
|
|
|
(3,102 |
) |
|
|
450 |
|
|
|
736 |
|
|
|
7 |
|
|
|
(1,909 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 29,
2013
|
|
$ |
635,129 |
|
|
$ |
2,279,697 |
|
|
$ |
1,016,214 |
|
|
$ |
8,132 |
|
|
$ |
3,939,172 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible Assets |
Intangible
assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description
|
|
As of June 29,
2013 |
|
|
As of September 29, 2012 |
|
|
Gross
Carrying
Value |
|
|
Accumulated
Amortization |
|
|
Gross
Carrying
Value |
|
|
Accumulated
Amortization |
|
Developed technology
|
|
$ |
3,813,551 |
|
|
$ |
1,013,545 |
|
|
$ |
3,784,689 |
|
|
$ |
788,274 |
|
In-process research and
development
|
|
|
193,000 |
|
|
|
— |
|
|
|
227,000 |
|
|
|
— |
|
Customer relationships and
contracts
|
|
|
1,101,244 |
|
|
|
273,627 |
|
|
|
1,097,842 |
|
|
|
205,612 |
|
Trade names
|
|
|
238,026 |
|
|
|
77,878 |
|
|
|
240,092 |
|
|
|
60,318 |
|
Patents
|
|
|
12,598 |
|
|
|
8,293 |
|
|
|
11,417 |
|
|
|
7,906 |
|
Business
licenses
|
|
|
2,616 |
|
|
|
545 |
|
|
|
2,577 |
|
|
|
344 |
|
Non-competition
agreements
|
|
|
290 |
|
|
|
280 |
|
|
|
310 |
|
|
|
223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals
|
|
$ |
5,361,325 |
|
|
$ |
1,374,168 |
|
|
$ |
5,363,927 |
|
|
$ |
1,062,677 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Remaining Amortization Expense |
The estimated
remaining amortization expense as of June 29, 2013 for each of
the five succeeding fiscal years was as follows:
|
|
|
|
|
Remainder of Fiscal
2013
|
|
$ |
111,125 |
|
Fiscal 2014
|
|
|
399,328 |
|
Fiscal 2015
|
|
|
384,454 |
|
Fiscal 2016
|
|
|
370,660 |
|
Fiscal 2017
|
|
|
361,484 |
|
|